pargyline has been researched along with Cerebral Ischemia in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strasser, A | 1 |
| Yasuma, Y | 1 |
| McCarron, RM | 1 |
| Ishii, H | 1 |
| Stanimirovic, D | 1 |
| Spatz, M | 1 |
1 other study available for pargyline and Cerebral Ischemia
| Article | Year |
|---|---|
Effect of nitro-L-arginine on cerebral blood flow and monoamine metabolism during ischemia/reperfusion in the mongolian gerbil.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Arginine; Biogenic Monoamines; Body T | 1994 |